Growth Metrics

Novavax (NVAX) Cash from Investing Activities (2016 - 2025)

Novavax has reported Cash from Investing Activities over the past 16 years, most recently at $20.5 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $20.5 million for Q4 2025, down 85.78% from a year ago — trailing twelve months through Dec 2025 was -$78.3 million (up 61.64% YoY), and the annual figure for FY2025 was -$78.3 million, up 61.64%.
  • Cash from Investing Activities for Q4 2025 was $20.5 million at Novavax, up from -$136.5 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for NVAX hit a ceiling of $144.0 million in Q4 2024 and a floor of -$372.7 million in Q2 2024.
  • Median Cash from Investing Activities over the past 5 years was -$14.6 million (2021), compared with a mean of -$16.7 million.
  • Peak annual rise in Cash from Investing Activities hit 1686.33% in 2024, while the deepest fall reached 4691.19% in 2024.
  • Novavax's Cash from Investing Activities stood at -$16.4 million in 2021, then crashed by 34.83% to -$22.1 million in 2022, then soared by 58.86% to -$9.1 million in 2023, then skyrocketed by 1686.33% to $144.0 million in 2024, then crashed by 85.78% to $20.5 million in 2025.
  • The last three reported values for Cash from Investing Activities were $20.5 million (Q4 2025), -$136.5 million (Q3 2025), and $111.1 million (Q2 2025) per Business Quant data.